Thermo Fisher Scientific | TMO - Aktuelle Verpflichtungen

Aktienkurs
469.71
Täglich Wechseln
3.01 0.64%
Monatlich
-4.29%
Jährlich
10.72%
Q2 Prognose
459.66




Aktuelle Verpflichtungen Veränderung Datum
Abbott USD 16.5B 1.91B 2025-12
Agilent USD 2.23B 113M 2025-12
Becton, Dickinson and Co. USD 8.76B 448M 2025-12
Bio Techne USD 140.43M 4.12M 2025-12
Bio-Rad Laboratories USD 517M 5.3M 2025-12
Boston Scientific USD 5.44B 111M 2025-12
Bruker USD 1.28B 11.1M 2025-12
Charles River Laboratories USD 1.12B 1.57M 2025-12
Danaher USD 7.46B 653M 2026-03
Dentsply International USD 1.34B 62M 2025-12
Edwards Lifesciences USD 1.81B 225.7M 2025-12
General Electric Aerospace USD 40.03B 1.05B 2026-03
Henry Schein USD 3.23B 79M 2025-12
Illumina USD 1.59B 377M 2025-12
Intuitive Surgical USD 2.51B 3.2M 2026-03
IQVIA Holdings USD 8.34B 170M 2025-12
Laboratory Of America USD 2.82B 194.3M 2025-12
Medtronic USD 9.5B 440M 2025-12
Mettler Toledo International USD 1.2B 5.99M 2025-12
Myriad Genetics USD 133.8M 14.2M 2025-12
Olympus JPY 400.73B 106.59B 2025-12
OraSure Technologies USD 39.8M 453K 2025-12
Quest Diagnostics USD 2.18B 101M 2026-03
Repligen USD 135.83M 4.69M 2025-12
Revvity USD 1.33B 108.5M 2025-12
Stryker USD 7.79B 380M 2025-12
Thermo Fisher Scientific USD 14.62B 568M 2026-03
Veracyte USD 59.94M 12.22M 2025-12
Waters USD 1.24B 11.8M 2025-12
Zimmer Biomet Holdings USD 2.58B 180.8M 2025-12